Michael Zinda, EVP, Chief Scientific Officer at Repare Therapeutics Inc. (RPTX), sold 1,200 shares at $12.04 ($14K) on 2023-06-06, disclosed to the SEC on 2023-06-07.
Scheduled sale ($14k) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RPTX | SELL | 2024-03-27 | $6K | — | Filing → |
| RPTX | SELL | 2023-06-09 | $189K | — | Filing → |
| RPTX | SELL | 2022-03-16 | $6K | — | Filing → |